Cargando…

Prognostic Value of the Glasgow Prognostic Score on Overall Survival in patients with Advanced Non-Small Cell Lung Cancer

Background: Findings from previous studies regarding the association between the Glasgow Prognostic Score (GPS) and overall survival (OS) of patients with advanced non-small cell lung cancer (NSCLC) were limited. This study aimed to investigate the prognostic value of GPS in patients with advanced N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Mingmei, Zhao, Yun, He, Jianbo, Wu, Huanqiong, Pan, Yujia, Yu, Qitao, Zhou, Shaozhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974889/ https://www.ncbi.nlm.nih.gov/pubmed/33758615 http://dx.doi.org/10.7150/jca.52215

Ejemplares similares

The predictive value of pretreatment haemoglobin-to-red cell distribution width ratio for overall survival of patients with advanced non-small cell lung cancer: a propensity score matching analysis
por: Jiang*, Huiqin, et al.
Publicado: (2021)

Predictive value of pretreatment albumin‐to‐alkaline phosphatase ratio for overall survival for patients with advanced non‐small cell lung cancer
por: Zhou, Shaozhang, et al.
Publicado: (2020)

Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer
por: Minami, Seigo, et al.
Publicado: (2017)

Pretreatment plasma d-dimer levels as an independent prognostic factor for overall survival among patients with advanced non-small-cell lung cancer
por: Liu, Qianfei, et al.
Publicado: (2020)

The Association between Pretreatment anemia and Overall Survival in Advanced Non-small Cell lung Cancer: A Retrospective Cohort Study Using Propensity Score Matching
por: Huang, Yucong, et al.
Publicado: (2022)

Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer
por: Stokke, Kristin, et al.
Publicado: (2022)

Prognostic Value of Pretreatment Albumin-to-Alkaline Phosphatase Ratio in Extensive-Disease Small-Cell Lung Cancer: A Retrospective Cohort Study
por: Zhou, Shaozhang, et al.
Publicado: (2020)

Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis
por: Lu, Lingling, et al.
Publicado: (2021)

Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis
por: Xie, Yulian, et al.
Publicado: (2023)

Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score
por: Hirahara, Noriyuki, et al.
Publicado: (2020)

Prognostic Value of Glasgow Prognostic Score in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Chuan-Long, et al.
Publicado: (2022)

Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) Patients
por: Lv, Yongbin, et al.
Publicado: (2017)

The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
por: Kinoshita, Akiyoshi, et al.
Publicado: (2013)

Prognostic value of preoperative modified Glasgow prognostic score in surgical non-small cell lung cancer: A meta-analysis
por: Yang, Chenli, et al.
Publicado: (2023)

Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy
por: Chen, Shubin, et al.
Publicado: (2021)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
por: Tong, Tongyu, et al.
Publicado: (2020)

The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
por: Zhang, Huan, et al.
Publicado: (2020)

Postoperative survival According to the Glasgow Prognostic Score in Patients with Resected Lung Adenocarcinoma
por: Machida, Yuichiro, et al.
Publicado: (2016)

The prognostic value of pretreatment Glasgow Prognostic Score in patients with esophageal cancer: a meta-analysis
por: Wang, Yan, et al.
Publicado: (2019)

Glasgow prognostic score and combined positive score for locally advanced rectal cancer
por: Feng, Yanru, et al.
Publicado: (2022)

Prognostic role of Glasgow prognostic score in patients with colorectal cancer: evidence from population studies
por: Liu, Yangyang, et al.
Publicado: (2017)

Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study
por: Kasahara, Kenta, et al.
Publicado: (2022)

The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma
por: Tian, Rui, et al.
Publicado: (2016)

Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer
por: Chang, Pei-Hung, et al.
Publicado: (2017)

Prognostic value of postdiagnostic inflammation-based scores in short-term overall survival of advanced pancreatic ductal adenocarcinoma patients
por: Xiao, Yuanyuan, et al.
Publicado: (2017)

The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer
por: Hanai, Nobuhiro, et al.
Publicado: (2018)

Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients
por: Lu, Xin, et al.
Publicado: (2018)

Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)
por: Vernerey, Dewi, et al.
Publicado: (2016)

The relationship between glasgow prognostic score and serum tumor markers in patients with advanced non-small cell lung cancer
por: Jiang, Ai-Gui, et al.
Publicado: (2015)

The application of the Glasgow prognostic score to predict the survival in patients with metastatic pancreatic carcinoma
por: Mohammed, Amrallah A., et al.
Publicado: (2022)

A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer
por: Zhang, Yongchao, et al.
Publicado: (2022)

Is the Glasgow Prognostic Score Applicable to Both Early- and Advanced-Stage Gastric Cancers?
por: Wakahara, Tomoyuki, et al.
Publicado: (2017)

Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score
por: Seebacher, Veronika, et al.
Publicado: (2018)

Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients
por: Choi, Kyeong Woon, et al.
Publicado: (2014)

Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer
por: Zhou, Jiahui, et al.
Publicado: (2021)

Predictive value of the modified Glasgow Prognostic Score for the therapeutic effects of molecular-targeted drugs on advanced renal cell carcinoma
por: Ohmura, Hirofumi, et al.
Publicado: (2017)

Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer
por: Jiang, X, et al.
Publicado: (2012)

The prognostic value of the Naples prognostic score for patients with non-small-cell lung cancer
por: Peng, Si-Min, et al.
Publicado: (2022)

Glasgow prognostic score predicts prognosis of non-small cell lung cancer: a meta-analysis
por: Zhu, Lucheng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9kl1r9ldn372e14k2ei336f7pe